Categories: All postsCannabis

Green Thumb Industries is a Top Pick for Q3, says Echelon

‘If it ain’t broke’ should be the motto when it comes to US cannabis name Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News CSE:GTII) says Echelon Capital Markets analyst Andrew Semple who renewed GTII’s status as a Top Pick in a report to clients Friday.

Semple has put GTII into Echelon’s Top Picks Portfolio for the last three quarters, where the stock outperformed the tracking group average for all those time periods, including for the Q2 where GTII returned a massive 65 per cent.

“We look for GTI to follow through on the outperformance streak in Q320,” said Semple in his report.

“Recent updates show the Company continues to operationalize store locations at a faster pace than we have modelled, leaving potential for further financial and operational outperformance. Industry data points have also been encouraging, suggesting that cannabis demand in the Company’s markets is developing (e.g., Illinois) or recovering (e.g., Nevada) at a faster pace than expected,” Semple wrote.

Chicago-based Green Thumb is a US multi-state operator with 13 manufacturing facilities and licenses for 96 retail locations and operations across 12 US markets. At the end of June, GTII announced the opening of its fifth Essence brand store in the Las Vegas area, representing the company’s 48th retail location in the US.

Green Thumb currently has licenses for six more stores in Nevada, where tourism has begun to open back up even as the state’s COVID-19 case numbers have recently been the highest since the pandemic began. This past week, Green Thumb also opened a new store in Duncansville, Pennsylvania, under the company’s Rise banner.

With his update, Semple has maintained his “Buy” rating and C$20.00 target price, which at press time represented a projected 12-month return of 54.9 per cent. The analyst thinks GTII will generate fiscal 2020 revenue and adjusted EBITDA of $457.3 million and $114.1 million, respectively.

Semple said Green Thumb is fully funded for its operations and buildout plans, with no pending, announced M&A transactions, and the analyst figures GTII is one of just a few cannabis operators currently generating operating cashflow, which he attributes to its scale in a number of markets that has allowed it to get to profitability “far quicker than many of its peers,” Semple said.

As for potential catalysts over the third quarter, Semple wrote, “We look for GTI to make further progress on operational milestones, primarily store openings. We also note the potential for M&A and license awards to add to the Company’s portfolio of assets. Though Q220 results may be somewhat off-trend due to COVID-19 related regulatory emergency measures, we believe financial updates should be broadly positive. Investors should watch for positive commentary on the recovery of COVID-19 impacted markets such as Massachusetts and Nevada, while industry data for other core markets such as Illinois and Pennsylvania suggest the Company’s robust growth in those markets continues.”

Semple reported that over the second quarter, GTII’s 65.2 per cent return was better than his tracking group average return of 20.3 per cent and the TSX Cannabis Index’s return of 9.0 per cent.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: gtii
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

19 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

19 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

20 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

1 day ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago